uploads///Q baby care

Procter & Gamble: Baby, Feminine and Family Care’s Weak 1Q16

By

Nov. 9 2015, Updated 2:05 a.m. ET

Baby, Feminine and Family Care’s 1Q16 results

Procter & Gamble’s (PG), or P&G’s, Baby, Feminine and Family Care net revenue came in at $4.7 billion in 1Q16. This was 12% lower than 1Q15. Organic sales for this segment fell 3% as pricing benefits along with product mix were more than offset by lower volume in each of the three businesses.

Article continues below advertisement

Fall in volume

In the United States, baby care value share was up nearly one basis point over a year ago, with Swaddlers growing value share over two basis points from last year. However, baby care volume fell due to competitive activity and increased pricing.

Feminine care organic sales fell primarily due to devaluation pricing in developing markets and pipeline inventory from the adult incontinence launch in the base period in the United States and Western Europe. Feminine care volume fell due to price increases in the previous fiscal year.

Family care organic sales were down by mid-single digits due to exiting underperforming product lines in Mexico and distribution losses in Canada. Changing consumer habits have increased competition across the globe. Like P&G, Kimberly-Clark Corporation (KMB), The Clorox Company (CLX), and Unilever (UL) are focusing on innovation and new technology to improve consumer value.

Article continues below advertisement

Improve point-of-market entry

The company plans to accelerate premium innovations on both taped and pull-on diapers to restore its competitiveness at the top end of the market. P&G is also strengthening its selling resources and programs for baby stores. The company also plans to improve its point-of-market entry programs to deliver higher awareness and more Pampers trials among new moms.

Reducing number of agency relationships

P&G is planning to simplify and reduce its number of agency relationships, focusing on upgrading agency capability to improve creative quality and communication effectiveness at a lower cost. As part of this plan, the company will be focusing on profitable premium-tier tissues in Mexico, and de-emphasizing conventional lower-value tissue products.

P&G has exposure to the iShares Dow Jones US ETF (IYY), with ~1.0%[1. Updated October 26, 2015] of the total weight of the portfolio.

Advertisement

More From Market Realist

  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.